MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism

MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism

MDMX is overexpressed in the vast majority of patients with acute myeloid leukemia (AML). We report that MDMX overexpression increases preleukemic stem cell (pre-LSC) number and competitive advantage. Utilizing five newly generated murine models, we found that MDMX overexpression triggers progressio...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Ueda, K, Kumari, R, Schwenger, E, Wheat, JC, Bohorquez, O, Narayanagari, S-R, Taylor, SJ, Carvajal, LA, Pradhan, K, Bartholdy, B, Todorova, TI, Goto, H, Sun, D, Chen, J, Shan, J, Song, Y, Montagna, C, Xiong, S, Lozano, G, Pellagatti, A, Boultwood, J, Verma, A, Steidl, U
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Cell Press 2021

Míreanna comhchosúla

Preleukemic stem cells: leave it or not?
de réir: Minhua Su, et al.
Foilsithe / Cruthaithe: (2020-04-01)

Induction of AML Preleukemic Fusion Genes in HSPCs and DNA Damage Response in Preleukemic Fusion Gene Positive Samples
de réir: Pavol Kosik, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells
de réir: Shayda Hemmati, et al.
Foilsithe / Cruthaithe: (2017-11-01)

Modelling the progression of a preleukemic stage to overt leukemia in children with down syndrome
de réir: Labuhn, M, et al.
Foilsithe / Cruthaithe: (2018)

Chemical instability and promiscuity of arylmethylidenepyrazolinone-based MDMX inhibitors
de réir: Stefaniak, J, et al.
Foilsithe / Cruthaithe: (2018)

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
de réir: Zuzana Mrkvová, et al.
Foilsithe / Cruthaithe: (2019-06-01)

Preleukemic Hematopoietic Stem Cells in Human Acute Myeloid Leukemia
de réir: M. Ryan Corces, et al.
Foilsithe / Cruthaithe: (2017-11-01)

MDMX elevation by a novel Mdmx–p53 interaction inhibitor mitigates neuronal damage after ischemic stroke
de réir: Haomin Yan, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Solitary Preleukemic Granulocytic Sarcoma as a Cause of Small Bowel Obstruction
Foilsithe / Cruthaithe: (2007-06-01)

Mismatch repair deficient hematopoietic stem cells are preleukemic stem cells.
de réir: Yulan Qing, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML
de réir: Tracy Murphy, et al.
Foilsithe / Cruthaithe: (2019-08-01)

Controlling the Mdm2-Mdmx-p53 Circuit
de réir: David L. Waning, et al.
Foilsithe / Cruthaithe: (2010-05-01)

Targeting MDMX for Cancer Therapy: Rationale, Strategies, and Challenges
de réir: De-Hua Yu, et al.
Foilsithe / Cruthaithe: (2020-08-01)

Acute lymphoblastic leukemia with aleukemic prodrome: preleukemic dynamics and possible mechanisms of immunosurveillance
de réir: Olga Zimmermannova, et al.
Foilsithe / Cruthaithe: (2017-06-01)

Incidence of common preleukemic gene fusions in umbilical cord blood in Slovak population.
de réir: Milan Škorvaga, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.
de réir: Jan, M, et al.
Foilsithe / Cruthaithe: (2012)

Patients with spontaneous remission of high-risk MDS and AML show persistent preleukemic clonal hematopoiesis
de réir: Victoria V. Grunwald, et al.
Foilsithe / Cruthaithe: (2019-09-01)

Preleukemic phase of chronic myelogenous leukemia: A diagnostic dilemma highlighting the significance of integrated reporting
de réir: Neelum Mansoor, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS.
de réir: Barreyro, L, et al.
Foilsithe / Cruthaithe: (2012)

Hinokiflavone Inhibits MDM2 Activity by Targeting the MDM2-MDMX RING Domain
de réir: Viktoria K. Ilic, et al.
Foilsithe / Cruthaithe: (2022-04-01)

Transcription and methylation analyses of preleukemic promyelocytes indicate a dual role for PML/RARA in leukemia initiation
de réir: Coline Gaillard, et al.
Foilsithe / Cruthaithe: (2015-08-01)

Role of the N-terminal lid in regulating the interaction of phosphorylated MDMX with p53
de réir: Chan, Jane Vin, et al.
Foilsithe / Cruthaithe: (2018)

A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein.
de réir: Georgios Valianatos, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice
de réir: Marta Isidro-Hernández, et al.
Foilsithe / Cruthaithe: (2023-08-01)

“Preleukemic or smoldering” chronic myelogenous leukemia (CML):BCR-ABL1 positive: A brief case report
de réir: John M. Bennett, et al.
Foilsithe / Cruthaithe: (2015-01-01)

MDM2 and MDMX bind and stabilize the p53-related protein p73
de réir: Ongkeko, W, et al.
Foilsithe / Cruthaithe: (1999)

MDMX in Cancer: A Partner of p53 and a p53-Independent Effector
de réir: Lin W, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Oncogenic functions of hMDMX in <it>in vitro </it>transformation of primary human fibroblasts and embryonic retinoblasts
de réir: van der Burg Marja JM, et al.
Foilsithe / Cruthaithe: (2011-09-01)

Predicted functions of MdmX in fine-tuning the response of p53 to DNA damage.
de réir: Sohyoung Kim, et al.
Foilsithe / Cruthaithe: (2010-02-01)

An Anti-Invasive Role for Mdmx through the RhoA GTPase under the Control of the NEDD8 Pathway
de réir: Lara J. Bou Malhab, et al.
Foilsithe / Cruthaithe: (2024-09-01)

Spliceosome mutations: 1 plus 1 does not always equal 2
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2020)

Reduced translation of GATA1 in Diamond-Blackfan anemia.
de réir: Boultwood, J, et al.
Foilsithe / Cruthaithe: (2014)

SF3B1 mutant myelodysplastic syndrome: Recent advances
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2020)

Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2016)

The reality of pervasive transcription.
de réir: Clark, M, et al.
Foilsithe / Cruthaithe: (2011)

Searching for novel MDM2/MDMX dual inhibitors through a drug repurposing approach
de réir: Keting Li, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Study on the design, synthesis, and activity of anti-tumor staple peptides targeting MDM2/MDMX
de réir: Jian Yang, et al.
Foilsithe / Cruthaithe: (2024-06-01)

Stress-induced alternative splice forms of MDM2 and MDMX modulate the p53-pathway in distinct ways.
de réir: Aishwarya G Jacob, et al.
Foilsithe / Cruthaithe: (2014-01-01)

This pervasive day : the potential and perils of pervasive computing /
de réir: Pitt, Jeremy
Foilsithe / Cruthaithe: (2012)

Molecular mechanism of CCDC106 regulating the p53-Mdm2/MdmX signaling axis
de réir: Ting Zhou, et al.
Foilsithe / Cruthaithe: (2023-12-01)